Migdal Insurance & Financial Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-99	Closed	-$12K	–	716
2019 Q4	$12K	Hold	99	–	–	﹤0.01%	699
2019 Q3	$10K	Sell	99 -34,652	-100%	-$3.63M	﹤0.01%	711
2019 Q2	$3.79M	Hold	34,751	–	–	0.1%	104
2019 Q1	$3.88M	Sell	34,751 -286,885	-89%	-$31.5M	0.09%	112
2018 Q4	$31M	Sell	321,636 -54,472	-14%	-$5.78M	0.7%	28
2018 Q3	$45.9M	Buy	376,108 +41	+0%	+$4.83K	0.95%	22
2018 Q2	$41.4M	Sell	376,067 -1,975	-0.5%	-$211K	0.98%	23
2018 Q1	$40.4M	Buy	378,042 +934	+0.2%	+$104K	0.95%	28
2017 Q4	$40.3M	Buy	377,108 +17,924	+5%	+$1.92M	1%	27
2017 Q3	$39.9M	Sell	359,184 -159	-0%	-$17K	0.95%	29
2017 Q2	$37.1M	Sell	359,343 -324	-0.1%	-$31.9K	0.84%	34
2017 Q1	$35.2M	Sell	359,667 -322,689	-47%	-$30.9M	0.84%	33
2016 Q4	$60.4M	Buy	682,356 +144,528	+27%	+$13.2M	1.53%	20
2016 Q3	$51.9M	Buy	+537,828	New	+$51.2M	1.49%	19
2016 Q1	–	Sell	-36,270	Closed	-$4.09M	–	123
2015 Q4	$4.09M	Buy	+36,270	New	+$3.94M	0.12%	78

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Migdal Insurance & Financial Holdings's IBB Position: Q1 2020 in Review

Migdal Insurance & Financial Holdings sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 99 shares — an estimated $12K sold.

Migdal Insurance & Financial Holdings first reported a position in IBB in Q4 2015 and held it in 15 quarters. The position peaked at $60.4M in Q4 2016. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Migdal Insurance & Financial Holdings reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 99 iShares Biotechnology ETF shares in Q1 2020, an estimated $12K.
Migdal Insurance & Financial Holdings first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 15 quarters.
Migdal Insurance & Financial Holdings's iShares Biotechnology ETF position peaked at $60.4M in Q4 2016.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2020, filed 12 May 2020.